Prostaglandins

References

• Kurzrock R, Lieb CC. Biochemical studies of human semen. II. The action of semen on the human uterus. Proc Soc Exp Biol Med 1930; 28: 268–71
   Google Scholar
• Goldblatt MW. A depressor substance in seminal fluid. J Soc Chem Ind 1933; 52: 1056–9
   Google Scholar
• von Euler US. On the specific vasodilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol (Lond) 1936; 88: 213–9
   Google Scholar
• Eliasson R. Studies on prostaglandins: occurrence, formation and biological actions. Acta Physiol Scand 1959; 46(Suppl 158): 1–52
   Google Scholar
• Bergstrom S, Sjövall J. The isolation of prostaglandin E from sheep prostate glands. Acta Chem Scand 1960; 14: 1701–6
   Google Scholar
• Bergstrom S, Ryhage R, Samuelsson B, et al. The structure of prostaglandins E1, F1, and F2. Acta Chem Scand 1962; 16: 501–11
   Google Scholar
• Ferreira SH, Vane JR. Mode of action of antiinflammatory agents which are prostaglandin synthetase inhibitors. In: Vane JR, Ferreira SH, eds. Antiinflammatory drugs. New York: Springer-Verlag, 1979: 348–98
   Google Scholar
• Karim SM, Hillier K. Physiological roles and pharmacological actions of prostaglandins in relation to human reproduction. In: Karim SM, ed. Advances in prostaglandin research, prostaglandins and reproduction. Lancaster, England: MTP Press, 1975: 23–76
   Google Scholar
• Liggins GC. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2. Prostaglandins 1979; 18: 167–72
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Eneroth P, Bygdeman M. Treatment with a single vaginal suppository containing 15 methyl PGF2α methyl ester at expected time of menstruation. Prostaglandins 1979; 17: 469–81
   PubMed Web of Science ®Google Scholar
• Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44:787–92
   PubMed Web of Science ®Google Scholar
• Marx JL. Dysmenorrhea: basic research leads to a rational therapy. Science 1979; 205: 175–6
   PubMed Web of Science ®Google Scholar
• Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 1973; 51: 220–5
   PubMed Web of Science ®Google Scholar
• Olley PM, Coceani F, Rowe RD. Role of prostaglandins E1 and E2 in the management of neonatal heart disease. Adv Prostaglandin Thromboxane Res 1978; 4: 345–54
   PubMedGoogle Scholar
• Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530–3
   PubMed Web of Science ®Google Scholar
• Carlson LA, Eriksson I. Femoral-artery infusion of prostaglandin E1 in severe peripheral vascular disease. Lancet 1973; 1: 155–6
   PubMed Web of Science ®Google Scholar
• Olsson AG, Carlson LA. Prostaglandin E1 in ischemic peripheral artery disease. In: Abstract program, Fourth International Prostaglandin Conference, Washington, DC. 1979: 89
   Google Scholar
• Szczeklik A, Gryglewski RJ, Szczeklik J, el al. Treatment of peripheral artery disease with prostacyclin. In: Abstract program,17 p 115
   Google Scholar
• Data JL, Martin WB, DePree HE, et al. Prostaglandin E1 for Raynaud's disease. In: Abstract program,17 p 23
   Google Scholar
• Mathe AA, Hedqvist P, Holmgren A, et al. Bronchial hyperreactivity to prostaglandin F2 and histamine in patients with asthma. Br Med J 1973; 1: 193–6
   PubMed Web of Science ®Google Scholar
• Green K, Hedqvist P, Svanborg N. Increased plasma levels of 15 keto 13,14,-dihydro PGF2α, after allergen provoked asthma in man. Lancet 1974;2: 1419–21
   PubMed Web of Science ®Google Scholar
• Smith AP, Cuthbert MF. The response of normal and asthmatic subjects to prostaglandins E2 and F2α by different routes, and their significance in asthma. Adv Prostaglandin Thromboxane Res 1976; 1: 449–59
   PubMedGoogle Scholar
• Szentivanyi A. The beta-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy Clin Immunol 1968; 42: 203–32
   Web of Science ®Google Scholar
• Lichtenstein LM, De Bernardo R. The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release. J Immunol 1971; 107: 1131–6
   PubMed Web of Science ®Google Scholar
• Rosenthale M. Bronchodilator activity of the prostaglandin PGE2. Pharmacologist 1968; 10: 175–80
   Google Scholar
• Lee JB. The renal prostaglandins and blood pressure regulation. Adv Prostaglandin Thromboxane Res 1976; 2: 573–85
   PubMedGoogle Scholar
• Bolger PM, Eisner GM, Ramwell PW, et al. Renal actions of prostacyclin. Nature (Lond) 1978; 271: 467–9
   Google Scholar
• Lee JB, McGiff JC, Kannegiesser H, et al. Prostaglandin A2: antihypertensive and renal effects. Ann Intern Med 1971; 74: 703–10
   PubMed Web of Science ®Google Scholar
• Robert A. Antisecretory, antiulcer cytoprotective and diarrheaogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res 1976; 2: 507–15
   PubMedGoogle Scholar
• Tonnessen MG, Jubiz W, Moore JG, et al. Circadian variation of prostaglandin E (PGE) production in human gastric juice. Am J Dig Dis 1974; 19: 644–8
   PubMedGoogle Scholar
• Cohen MM, Hughes H, Suedfeld G. Distribution of prostaglandin E in rat stomach. In: Abstract program.17 p 21
   Google Scholar
• Karim SM, Fung WP. Effects of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man. Adv Prostaglandin Thromboxane Res 1976; 2: 529–34
   PubMedGoogle Scholar
• Fung WP, Karim SM, Tye CY. Effect of 15(R)15 methylprostaglandin E2 methyl ester on healing of gastric ulcers: controlled endoscopic study. Lancet 1974; 2: 10–2
   PubMed Web of Science ®Google Scholar
• Vane JR. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res 1976; 2: 791–8
   PubMedGoogle Scholar
• Zurier RB. Prostaglandins, inflammation, and asthma. Arch Intern Med 1974; 133: 101–10
   PubMedGoogle Scholar
• Ham EA, Cirillo VJ, Zanetti M, et al. Studies on the mode of action of non-steroidal antiinflammatory agents. In: Ramwell PW, Pharris BB, eds. Cellular biology. New York: Plenum Press. 1972: 345–52
   Google Scholar
• Kuehl FA, Humes JL, Egan RW, et al. Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature (Lond) 1977; 265: 170–3
   Google Scholar
• Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975; 44: 147–59
   PubMed Web of Science ®Google Scholar
• Weissmann G. Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med 1972; 286: 141–7
   PubMed Web of Science ®Google Scholar
• Zurier RB, Weissmann G, Hoffstein S, et al. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 1974; 53: 297–309
   PubMed Web of Science ®Google Scholar
• Zurier RB, Hoffstein S, Weissmann G. Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins. Arthritis Rheum 1973; 16: 606–18
   PubMed Web of Science ®Google Scholar
• Bonta IL, Paraham MJ, Van Vliet L. Combination of theophylline and prostaglandin E1 as inhibitors of the adjuvant-induced arthritis syndrome of rats. Ann Rheum Dis 1978; 37: 212–7
   PubMed Web of Science ®Google Scholar
• Kayashima K, Koga T, Onoue K. Role of T lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus-derived cells in induction of the disease. J Immunol 1976; 117: 1878–82
   PubMed Web of Science ®Google Scholar
• Zurier RB, Quagliata F. Effect of prostaglandin E, on adjuvant arthritis. Nature (Lond) 1971; 234: 304–5
   Google Scholar
• Cochrane CG. Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol 1968; 9: 97–163
   PubMedGoogle Scholar
• Pflum LR, Graeme ML. The Arthus reaction in rats: a possible test for antiinflammatory and antirheumatic drugs. Agents Actions 1979; 9: 184–9
   PubMedGoogle Scholar
• Kunkel SL, Thrall RS, McCormick JR, et al. Suppression of immune complex vasculitis in rats by prostaglandins. J Clin Invest 1979; 64: 1525–9
   PubMed Web of Science ®Google Scholar
• Henney CS, Bourne HR, Lichtenstein LM. The role of cyclic 3′5′ adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol 1972; 108: 1526–34
   PubMed Web of Science ®Google Scholar
• Zurier RB, Cosgrove JM, Hinz CF. Enhancement by cyclic AMP and prostaglandin E1 of cytotoxicity mediated by human monocytes. (Abstr) Fed Proc 1975; 34: 1029
   Google Scholar
• Hahn BH. Cell mediated immunity in systemic lupus erythematosus. Clin Rheum Dis 1975; 1: 497–504
   Google Scholar
• Zurier RB, Damjanov I, Miller PL, et al. Prostaglandin E1 treatment prevents progression of nephritis in murine lupus erythematosus. J Clin Lab Immunol 1978; 1: 95–8
   Google Scholar
• Talal N. Animal models for systemic lupus erythematosus. Clin Rheum Dis 1975; 1: 485–92
   Google Scholar
• Krakauer KA, Torrey SB, Zurier RB. Prostaglandin E1 treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses. Clin Immunol Immunopathol 1978; 11: 256–66
   PubMedGoogle Scholar
• Bach MA. Differences in cyclic AMP changes after stimulation by prostaglandins and isoproterenol in lymphocyte subpopulation. J Clin Invest 1975; 55: 1074–81
   PubMed Web of Science ®Google Scholar
• Webb DR, Osheroff PL. Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sei USA 1976; 73: 1300–4
   PubMed Web of Science ®Google Scholar
• Webb DR, Nowowiejski I. The role of prostaglandins in the control of the primary 19S immune response to sRBC. Cell Immunol 1976; 33: 1–10
   Web of Science ®Google Scholar
• Karmali RA. Essential fatty acids and prostaglandins in regulation of autoimmunity in NZBxNZW F1 mice. Abstr 117, Golden Jubilee International Congress on Essential Fatty Acids and Prostaglandins, Minneapolis: 1980
   Google Scholar
• Hurd ER, Johnson JM, MacDonald PC, et al. Prevention of glomerulitis with prolonged survival of NZB/W F1 hybrid mice treated with an essential fatty acid deficient diet. Arthritis Rheum (in press)
   Google Scholar